Author: Wang, Ting; Yin, Huiquan; Li, Yan; Zhao, Lingxiao; Sun, Xiahui; Cong, Hua
Title: Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes Document date: 2017_4_3
ID: 1ay8y7li_46
Snippet: In summary, mucosal immunization with recombinant adenovirus vaccine expressing ubiquitin-conjugated multistage antigen segments (Ad-UMAS) is a potential vaccination route to elicit protective immune responses. Compared to other immunization routes, oral and nasal immunizations with Ad-UMAS elicit both robust systemic and mucosal immune responses, accompanied by a significant increase in survival rates after challenge with highly virulent parasit.....
Document: In summary, mucosal immunization with recombinant adenovirus vaccine expressing ubiquitin-conjugated multistage antigen segments (Ad-UMAS) is a potential vaccination route to elicit protective immune responses. Compared to other immunization routes, oral and nasal immunizations with Ad-UMAS elicit both robust systemic and mucosal immune responses, accompanied by a significant increase in survival rates after challenge with highly virulent parasites and a dramatic reduction in brain cyst burdens in vaccinated mice after challenge with mild strains of T. gondii. Therefore, the results of this study should contribute to the development of an effective and safe mucosal vaccine for preventing T. gondii infection.
Search related documents:
Co phrase search for related documents- immune response and mucosal immunization: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- immune response and mucosal robust systemic immune response: 1
- immune response and mucosal vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
- immune response and nasal oral immunization: 1, 2, 3
- immune response and protective immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- immune response and protective immune response elicit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- immune response and recombinant adenovirus vaccine: 1, 2, 3, 4, 5, 6, 7
- immune response and significant increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- immune response and study result: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- immune response and survival rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- immune response and ubiquitin conjugate: 1
- immune response and vaccinated mouse: 1, 2
- immune response and vaccination route: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- immunization route and mucosal immunization: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- immunization route and mucosal vaccine: 1, 2, 3
- immunization route and protective immune response: 1, 2
- immunization route and protective immune response elicit: 1
- immunization route and significant increase: 1, 2
- immunization route and vaccination route: 1, 2, 3, 4, 5, 6, 7, 8, 9
Co phrase search for related documents, hyperlinks ordered by date